Astegolimab structure
|
Common Name | Astegolimab | ||
---|---|---|---|---|
CAS Number | 2173054-79-8 | Molecular Weight | N/A | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | N/A | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of AstegolimabAstegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research[1]. |
Name | Astegolimab |
---|
Description | Astegolimab (MSTT 1041A; RG 6149) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab has the potential for chronic obstructive pulmonary disease (COPD) research[1]. |
---|---|
Related Catalog | |
Target |
ST2 |
References |
No Any Chemical & Physical Properties |